Teva shareholders approve amendments to Articles of Association and elect four directors at annual meeting

TEVA PHARMACEUTICAL INDUSTRIES LTD

Shareholders approved amendments to Articles, effective June 23, 2022, including eliminating minimum in-person board meetings and allowing chairman discretion on meetings in Israel.
Four directors elected: Amir Elstein, Roberto A. Mignone, Dr. Perry D. Nisen, Dr. Tal Zaks, each to serve until 2025 annual meeting.
Non-binding advisory vote on executive compensation approved with 424.6M for vs 137.8M against.
Appointment of Kesselman & Kesselman (PwC) as independent auditor approved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.